We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sen. Edward Kennedy (D-Mass.), chairman of the Health, Education, Labor and Pensions (HELP) Committee, and HELP Committee ranking member Sen. Mike Enzi (R-Wyo.) have called on Congress to act quickly on the "Genetic Information Nondiscrimination Act."
Becton Dickinson (BD) remains a solid bet for investors, thanks in part to its next-generation safety device to guard against hospital-acquired infections, an analyst says.
Medtronic's Physio-Control business has suspended U.S. shipments of external defibrillators and other products from its Redmond, Wash., facility in a move that could allow rival devicemakers to gain market share.
In Minnesota, physicians are reportedly up in arms over a new insurance rule that will force them to consult a third party before they can proceed with magnetic resonance imaging, positron emission tomography and computed tomography scans.
The poor understanding of device performance in magnetic resonance imaging (MRI) environments means that implantable devices "remain contraindicated for use with MRI," Biophan Technologies Vice President of Engineering Jeffrey Helfer said Jan. 8.
The FDA wants to prohibit companies from using certain cattle material to make drugs, biologics and medical devices to lower the risk of bovine spongiform encephalopathy (BSE or mad cow disease).
Conor Medsystems announced that the UK's Court of Appeal unanimously upheld a lower court decision to revoke the UK portion of a European paclitaxel-eluting stent patent that was licensed to Angiotech Pharmaceuticals.
Firms should establish special controls to ensure the safety and effectiveness of quality control (QC) materials for cystic fibrosis nucleic acid assays, the FDA said in a recent guidance.
Medtronic has launched a national print, television and online advertising campaign to raise awareness of sudden cardiac arrest (SCA), its risk factors and the role of implantable cardioverter-defibrillator (ICD) therapy, the firm said Jan. 15.